Gene Mack, CEO, GAIN Therapeutics, highlights early Phase Ib data showing GT-02287 may enhance neuroprotection across a wider spectrum of Parkinson’s patients regardless of genetic status.

Get key insights into Talkspace's Q2 2025 earnings, with 18% revenue growth, AI innovation, payer momentum, and expanding partnerships driving ...

Tariffs— Shawn Munsell stated, "Under the 10% tariff environment, our exposure without mitigation could approach $8 million ...

Q2 2025 Management View CEO Christopher C. Gibson emphasized the integration of Exscientia's technology into Recursion OS ...

Q2 2025 Management View CEO R. Jeffrey Bailly highlighted a strong second quarter, reporting "revenue grew 37% with 5% organic growth. Adjusted operating income increased 35%, and adjusted EPS grew 27 ...

Furthermore, the Company has been provided an update that its first orders of twenty (20) ElphaPex DG1+ miners are scheduled ...

Broadridge Financial Solutions (BR) shares gapped up 6.9% in Tuesday afternoon trading after initiating a stronger-than-expected growth outlook for fiscal-year 2026 on the heels of a double-beat on ...

Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) could see a strong end to the year, according to fresh technical analysis by ...

Analysts expect the San Jose, California-based company to report quarterly earnings at 44 cents per share, down from 62 cents ...

This List includes venture capital firms that invested in companies headquartered in the Greater Bay Area counties of Alameda, Contra Costa, Marin, Monterey, Napa, San Benito, San Francisco, San Mateo ...

How leading retailers use search intelligence to navigate AI overviews, optimize shopping ads, and win market share.

ADM topped Q2 EPS expectations despite softer sales and segment profits, narrowed full-year guidance, and sees biofuel policy ...